P

PROTTI A

Last name: PROTTI A

2017 (v1)

Publication

Metadata-only

Integrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis

Sgoifo A Bignamini A La Mantia L

Introduction: Fatigue is a frequent, disabling, and difficult to treat symptom in neurological disease and in other stress-related conditions; Integrated Imaginative Distention (IID) is a therapy combining muscular and imaginative relaxation, feasible also in disabled subjects; the DIMMI SI trial was planned to evaluate IID efficacy on fatigue....

Uploaded on: April 14, 2023
2010 (v1)

Publication

Metadata-only

Pregnancy and fetal outcomes after interferon-β exposure in multiple sclerosis.

Amato MP Portaccio E Ghezzi A

No description

Uploaded on: April 14, 2023
2014 (v1)

Publication

Metadata-only

Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical trial.

Laroni A Brogi D Morra VB

In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease relapses and delays disability progression. First dose administration of fingolimod is associated with a transient, dose-dependent decrease in heart rate (HR) in the 6 hours after drug intake.The aim of the study is to to assess safety and tolerability of the first dose...

Uploaded on: April 14, 2023